Clinical Site Services (CSS), a US-based specialist in patient-enrolment solutions for clinical trials, is changing its name to CSSi, reflecting its evolution to “a leader in global patient recruitment”.

Operating out of Glen Burnie, Maryland and active for more than 15 years in developing and implementing clinical-trial enrolment and retention programmes, CSSi started out as a site-performance management company.

It now has a “laser-like focus” on delivering on-time enrolment of patients for trial sponsors and contract research organisations, CSSi explained.

The company’s portfolio of integrated patient-recruitment and -retention programmes ranges from study start-up planning to global media buying, using innovative technologies to manage patient recruitment faster and more efficiently.

Local Enrollment Specialists

A key driver of success in global programmes, CSSi noted, is the company’s Local Enrollment Specialists (LES) service.

The LES team operates in more than 40 countries worldwide, offering experienced patient-recruitment professionals with strong knowledge of local ethics committees and regulatory bodies, as well as local language capabilities.

CSSi has worked with more than 2,000 geographically-dispersed trial sites worldwide, planning and executing recruitment campaigns in over 30 therapeutic areas. More than 350 enrolment plans have been implemented in the past 18 months, it says. 

Global image

“Sponsors and CROs have already found enormous success in partnering with us because of our global presence, working on large and complex protocols to increase performance and screenings at the site level,” commented CSSi president Chris Trizna.

“It makes sense for us to adopt a global image as part of our company name.”

The rebranding is a logical step in the company’s growth and “gives us an umbrella under which we can continue to expand our products, services, and client relationships”, Trizna added.

CSSi is “significantly more than a patient recruitment and site performance company”, he stressed, characterising the business as “truly a full-service, global patient enrolment solutions provider”.